Inclusion Body Myositis Pipeline Market Landscape Report 2025 Featuring Abcuro, Regeneron Pharmaceuticals, and Vandria
The "Inclusion Body Myositis - Pipeline Insight, 2025" report has been added to ResearchAndMarkets.com's offering.This report offers in-depth insights into the Inclusion Body Myositis (IBM) pipeline, ...
BioSpace16h
5 CAR T Cell Therapies With Autoimmune Readouts in 2025
Having established success in cancer, biopharma is now looking to leverage CAR T therapies against a new target, autoimmune ...
European Medical Journal5d
Rare Anti-HMGCR-Induced Immune-Mediated Necrotising Myopathy: A Case Report and Literature Review
An acute necrotising myopathy is a distinct form of uncommon muscle disease characterised by the rapid advancement of ...
Mystery surrounds DOGE acting administrator Amy Gleason after sudden rise to prominence
Amy Gleason, the acting administrator of the Department of Government Efficiency, had been a relatively low-profile health ...
Sana Makbul Has Autoimmune Condition Like Samantha Ruth Prabhu: 'My Body Cells Are Attacking Liver'
Sana Makbul reveals she has autoimmune hepatitis, a liver disease where her body attacks itself, similar to Samantha Ruth ...
Musk isn’t DOGE’s chief. Who is Amy Gleason?
Gleason is a former health-care executive and nurse who worked for the U.S. Digital Service, DOGE’s predecessor, and has advocated for better medical record-keeping.
Who is DOGE's newly identified administrator Amy Gleason? 'World-class talent'
The White House on Tuesday confirmed that 53-year-old Amy Gleason is currently serving as acting administrator of the Department of Government Efficiency.
Who Is Amy Gleason? White House Names Acting DOGE Administrator
Amy Gleason is the acting administrator of the Department of Government Efficiency (DOGE), a White House official told ...
Pneumonia now the leading cause of certified deaths in Malaysia
Pneumonia has become the leading cause of certified deaths in Malaysia while seasonal influenza remains a global health ...